Nutrition, metabolism, and cardiovascular diseases : NMCD · 2026
Chronic coffee consumption and diabetogenic risk: data from the PAMELA study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quarti-Trevano Fosca, Dell'Oro Raffaella, Ambrosino Pasquale, Cuspidi Cesare, Facchetti Rita, Grassi Guido
Аннотация
BACKGROUND AND AIM: The present study was designed to investigate a controversial issue, namely whether and to what extent chronic coffee consumption is associated with an increased diabetogenic risk.
METHODS AND RESULTS: We examined data collected cross-sectionally and prospectively in 1158 healthy subjects belonging to the general population of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study. Results collected at the cross-sectional examination performed at baseline show fasting serum glucose (89.4 ± 12.6 vs 89.9 ± 20.9 mg/dl, means ± SD, PNS) and incidence of impaired fasting glucose (IFG, 8.1%vs 5.5%, PNS) superimposable in coffee consumers (≥2-3 cups of coffee per day) and non-consumers. This was the case also when incidence of diabetes mellitus and use of antidiabetic drug treatment were examined. Furthermore, data collected at the 10-years follow-up examination show that the risk of new IFG and new diabetes mellitus was similar in coffee consumers and non-consumers.
CONCLUSIONS: The results of the present PAMELA study suggest that in our general population chronic consumption of coffee has a neutral long-term impact on glucose metabolism.
METHODS AND RESULTS: We examined data collected cross-sectionally and prospectively in 1158 healthy subjects belonging to the general population of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study. Results collected at the cross-sectional examination performed at baseline show fasting serum glucose (89.4 ± 12.6 vs 89.9 ± 20.9 mg/dl, means ± SD, PNS) and incidence of impaired fasting glucose (IFG, 8.1%vs 5.5%, PNS) superimposable in coffee consumers (≥2-3 cups of coffee per day) and non-consumers. This was the case also when incidence of diabetes mellitus and use of antidiabetic drug treatment were examined. Furthermore, data collected at the 10-years follow-up examination show that the risk of new IFG and new diabetes mellitus was similar in coffee consumers and non-consumers.
CONCLUSIONS: The results of the present PAMELA study suggest that in our general population chronic consumption of coffee has a neutral long-term impact on glucose metabolism.